Remedent, Inc. (REMI)
OTCMKTS · Delayed Price · Currency is USD
0.0090
-0.0010 (-10.00%)
At close: Jul 14, 2025
Accolade Market Cap
Remedent has a market cap or net worth of $173.07 thousand as of August 1, 2025. Its market cap has decreased by -95.27% in one year.
Market Cap
173.07K
Enterprise Value
n/a
Revenue
50.10K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since October 22, 1998, Remedent's market cap has decreased from 207.16K to 173.07K, a decrease of -16.45%. That is a compound annual growth rate of -0.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 173.07K | -83.67% |
| Dec 18, 2024 | 1.06M | -43.30% |
| Dec 14, 2023 | 1.87M | -43.51% |
| Dec 23, 2022 | 3.31M | 14.47% |
| Dec 31, 2020 | 2.89M | -10.18% |
| Dec 18, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 438.99M |
| American Oncology Network | 408.39M |
| Northwest Biotherapeutics | 376.73M |